Metagenomi, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Metagenomi Therapeutics, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 9, 2026, to conduct routine director elections and auditor ratification.
NASDAQ
Metagenomi, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Metagenomi, Inc. will hold its 2025 annual meeting of stockholders virtually on June 10, 2025, to elect a director and ratify the appointment of its independent registered public accounting firm.